If you missed BluePeak’s August Spotlight on Year-End Benefit Testing, here is a summary of the key takeaways and considerations for health plans preparing for the 2027 benefit year. The session explored significant Medicare Advantage and Part D changes, emerging compliance requirements, and the critical role year-end benefit testing plays in ensuring operational readiness, regulatory compliance, and a positive member experience.
2027 Changes Are Raising the Stakes
The 2027 plan year introduces several important Medicare Part D changes that require focused testing and validation. The standard deductible will increase from $615 to $700, while the member out-of-pocket threshold will increase from $2,100 to $2,400. In addition, the Medicare Drug Price Negotiation Program expands to include 15 newly selected drugs, including widely utilized diabetes and obesity therapies. These changes have implications for benefit design, claims adjudication, formulary administration, member cost sharing, and downstream reporting.
CMS has also clarified permissible approaches for providing zero-dollar prescription drug cost sharing for D-SNP members. Plans should evaluate eligibility processes, claims configuration, accumulator calculations, pharmacy point-of-sale functionality, and reporting processes to ensure eligible members consistently receive the intended benefit across all pharmacy settings.
On the Medicare Advantage side, plans are preparing for significant updates to the standardized Part C Explanation of Benefits (EOB) and new requirements affecting supplemental benefit administration. Organizations should assess impacts to member communications, debit card programs, vendor integrations, and reporting processes while monitoring final CMS guidance and implementation timelines.
Why Year-End Testing Matters
Year-end testing is more than a compliance exercise. It is the process of confirming that approved benefits translate accurately into system configuration, operational workflows, claim outcomes, and member communications before the new plan year begins.
For Part C, testing validates that deductibles, member cost sharing, maximum out-of-pocket limits, authorization requirements, network rules, and benefit limitations align with approved plan designs. For Part D, testing confirms that benefit phases, formulary requirements, utilization management programs, subsidies, discounts, and accumulators function correctly throughout the member journey.
Without comprehensive testing, configuration issues may not be identified until claims begin processing in production. These errors can lead to member disruption, operational inefficiencies, financial inaccuracies, compliance findings, and increased audit exposure. Identifying and resolving issues before implementation reduces risk and supports a smoother transition into the new benefit year.
Common Areas of Risk
Although regulations evolve each year, many testing findings continue to fall into familiar categories. Health plans commonly encounter issues involving:
- Cost-sharing and accumulator calculations
- Benefit mapping and configuration logic
- Authorization and referral requirements
- Eligibility and supplemental benefit rules
- Manual processing workflows
- Change management and implementation oversight
These risks often stem from complex benefit structures, delegated vendor relationships, multiple source documents, and late regulatory updates. Effective testing helps identify not only individual defects but also broader process and configuration issues that could affect members, operations, and compliance performance.
A Proven Framework for Readiness
Successful year-end testing follows a structured end-to-end approach. Organizations should begin by confirming approved benefits and business requirements, then translating those requirements into system rules and operational workflows. Test scenarios should evaluate both standard and high-risk claim situations, followed by validation of claim outcomes, member liability, notices, and reporting. Any identified issues should be remediated and retested before implementation.
For Part D, readiness activities should include formulary and utilization management validation, transition-of-care testing, point-of-sale adjudication review, benefit accuracy testing, and claims configuration analysis. For Part C, emphasis should remain on benefit accuracy, cost sharing, authorization processes, communications, and operational controls. This structured approach helps organizations strengthen readiness while reducing operational and compliance risk.
Looking Ahead
As CMS requirements continue to evolve, health plans face increasing pressure to ensure benefits operate exactly as approved and intended. Year-end benefit testing remains one of the most effective ways to validate benefit accuracy, support compliance readiness, and protect the member experience.
Organizations that invest in comprehensive testing before go-live are better positioned to identify issues early, support successful implementation, and enter the new plan year with confidence. With significant Medicare Advantage and Part D changes on the horizon for 2027, now is the time to confirm that systems, processes, vendors, and benefit configurations are prepared for day one.
